# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4252210 | F | Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
2. | ALA4252211 | F | Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
3. | ALA4252212 | F | Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
4. | ALA4252213 | F | Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
5. | ALA4252214 | F | Cytotoxicity against mouse EAC cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay | Mus musculus | 29 | cell-based format | Scientific Literature | ||
6. | ALA4252215 | F | Cytotoxicity against mouse EAC cells assessed as reduction in cell viability after 48 hrs by MTT assay | Mus musculus | 29 | cell-based format | Scientific Literature | ||
7. | ALA4252216 | F | Cytotoxicity against mouse DLA cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay | Mus musculus | 29 | cell-based format | Scientific Literature | ||
8. | ALA4252217 | F | Cytotoxicity against mouse DLA cells assessed as reduction in cell viability after 48 hrs by MTT assay | Mus musculus | 29 | cell-based format | Scientific Literature | ||
9. | ALA4252218 | F | Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
10. | ALA4252219 | F | Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 48 hrs by MTT assay | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
11. | ALA4252220 | F | Antitumor activity against mouse EAC cells implanted in Swiss albino mouse assessed as decrease in tumor volume at 25 mg/kg, ip administered every alternate day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
12. | ALA4252221 | F | Antitumor activity against mouse EAC cells implanted in Swiss albino mouse assessed as decrease in tumor volume at 50 mg/kg, ip administered every alternate day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
13. | ALA4252222 | F | Antitumor activity against mouse EAC cells implanted in ip dosed Swiss albino mouse assessed as decrease in tumor volume administered every alternate day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
14. | ALA4252223 | F | Antitumor activity against mouse EAC cells implanted in ip dosed Swiss albino mouse assessed as reduction in cell density administered every alternate day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
15. | ALA4252224 | F | Antitumor activity against mouse EAC cells implanted in ip dosed Swiss albino mouse assessed as reduction in ascite volume administered every alternate day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
16. | ALA4252225 | F | Antitumor activity against mouse EAC cells implanted in Swiss albino mouse assessed as mouse survival at 25 to 50 mg/kg, ip administered every alternate day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
17. | ALA4252226 | T | Toxicity in Swiss albino mouse implanted with mouse EAC cells assessed as induction of adverse effect on liver at 25 to 50 mg/kg, ip administered every alternate day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
18. | ALA4252227 | T | Toxicity in Swiss albino mouse implanted with mouse EAC cells assessed as induction of adverse effect on spleen at 25 to 50 mg/kg, ip administered every alternate day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
19. | ALA4252228 | F | Antitumor activity against mouse EAC solid tumor implanted in Swiss albino mouse assessed as reduction in tumor mass at 25 mg/kg, ip administered every alternate day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
20. | ALA4252229 | F | Antitumor activity against mouse EAC solid tumor implanted in ip dosed Swiss albino mouse assessed as reduction in tumor volume administered every alternate day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature |